What Is a Cancer Stage?

 

Following a diagnosis of cancer, the most important step is to accurately determine the stage of the cancer. The stage describes how far the cancer has spread. (Some cancers, such as leukemia, are not staged.) Each stage of cancer may be treated differently.

To begin evaluating and discussing treatment options with your health care team, you need to know the stage of your cancer.

There are many staging systems, but the TNM system is the most common. This system uses three different codes to describe the size and location of the tumor, whether it has spread to the lymph nodes around the tumor, and whether it can be found in other parts of the body. Specifically, “T” refers to the size and location of the tumor, “N” to the number of lymph nodes (tiny bean-shaped organs throughout the body that help fight infection) involved, and “M” to whether the cancer has spread (metastasized) to other parts of the body.

After the T, N, and M categories of your cancer have been identified, your doctor will combine this information to assign a stage (0 to IV) to your cancer. The higher the number, the more serious (advanced) the cancer is.

  • Stage 0 - precancer
  • Stage I - small cancer found only in the site where it started
  • Stage II - larger cancer that may have spread to the lymph nodes
  • Stage III - larger cancer that is also in the lymph nodes and possibly in nearby organs
  • Stage IV - cancer that has spread to a different part of the body from where it started
This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Cancer News
REFILE: Komen charity under microscope for funding, science

February 8, 2012 — NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it spends on grants to scientists working to understand the causes and develop effective new treatments for the disease.

US FDA panel votes against wider use of Amgen drug

February 8, 2012 — WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers.

US consumers want tougher probe of engineered salmon

February 8, 2012 — WASHINGTON (Reuters) - Three U.S. consumer groups petitioned the Food and Drug Administration on Tuesday to subject a new genetically engineered salmon to a more rigorous review process than is now in place before the fish can be approved as safe to eat.

Select news items provided by Reuters Health